
Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium
31.5.2026
0:00
39:56
Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.
Flere episoder fra "Deep Margin"



Gå ikke glip af nogen episoder af “Deep Margin” - abonnér på podcasten med gratisapp GetPodcast.








